Real-life effectiveness evaluation of the long-acting muscarinic antagonist aclidinium bromide (Eklira®) for the management of COPD in a routine UK primary care population - Study 1 (Real-life acceptability of Eklira)

First published 19/05/2014

Last updated 17/03/2015

EU PAS number:

EUPAS6573

Study

Finalised

Documents

Study protocol

Initial protocol

2014_05_19_(R03712a) Almirall Eklira study 1 protocol-v2_ENCEPP

English (155.71 KB - PDF)View document

Study results

REG_SUMMIT_abstract_FINAL_eklira_2014_11_14

English (68.28 KB - PDF)View document

Study report

Other information

Publications

Study publications

ENCePP Seal

ENCePP Seal documents

Secondary tabs